Researcher
Matthias Van Woensel
- Disciplines:Biomechanics, Morphological sciences, Neurosciences, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Member
From1 Aug 2013 → 31 Jul 2020 - Inborn Errors of Immunity (Lab)
Member
From16 Aug 2012 → 31 Jul 2013
Projects
1 - 1 of 1
- Evaluation of galectin-1 targeting drugs in combination with chemo-immunotherapy in the treatment of high-grade glioma.From1 Aug 2012 → 31 Dec 2016Funding: IWT personal funding - strategic basic research grants
Publications
1 - 10 of 14
- Tumor Targeting by Peptide-Decorated Gold Nanoparticles(2019)
Authors: Matthias Van Woensel
Pages: 2430 - 2444 - Histamine and T helper cytokine driven epithelial barrier dysfunction in allergic rhinitis(2018)
Authors: Brecht Steelant, Sven Seys, Laura Van Gerven, Matthias Van Woensel, Inge Kortekaas Krohn, Dominique Bullens, Karel Talavera Pérez, Guy Boeckxstaens, Jan Ceuppens, Peter Hellings
Pages: 951 - 963 - New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation(2018)
Authors: Matthias Van Woensel
Pages: 899 - 910 - Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth(2017)
Authors: Matthias Van Woensel, Joost Dejaegher, Ken Matsumoto, Petya Georgieva, Jochen Belmans, Raf Sciot, Max Mazzone, Steven De Vleeschouwer, Holger Gerhardt
Pages: 1629 - 1645 - Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy(2017)
Authors: Matthias Van Woensel, Abhishek Garg, Patrizia Agostinis, Jochen Belmans, Holger Gerhardt, Steven De Vleeschouwer
Pages: 1217 - Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing(2017)
Authors: Abhishek Garg, Lien Vandenberk, Matthias Van Woensel, Niels Vanthillo, Peter de Witte, Patrizia Agostinis
Pages: 832 - 843 - Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma(2017)
Authors: Abhishek Garg, Lien Vandenberk, Matthias Van Woensel, Jochen Belmans, Marco Schaaf, Steven De Vleeschouwer, Patrizia Agostinis
- Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes(2016)
Authors: Jeroen Plessers, Matthias Van Woensel, Dominique Bullens, Jef Pinxteren, Catherine Verfaillie
Pages: 1607 - 1619 - Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration(2016)
Authors: Matthias Van Woensel, Brecht Steelant, Stefaan Van Gool, Holger Gerhardt, Steven De Vleeschouwer
Pages: 71 - 81 - Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy(2016)
Authors: Matthias Van Woensel
Pages: 148 - 159
Patents
1 - 3 of 3
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)